Community Search
Hot Topics

Abstract submissions were considered for Hot Topics presentations in one of four areas: basic science, clinical science, clinical therapeutics, and comprehensive care. Just 12 abstracts, around 2% of all submissions, were selected for the lead author to give an oral talk about their work.

Like what you hear? You can also check out their poster and speak with them directly when they host their poster over the lunch hour.


WPC 2013 Hot Topics Presenters

Day 1 – October 2


Hot Topics

8-9AM
Plenary Hall 517ABC


Moderator: Thomas Gasser (Germany)

 

Michelle Lin (Canada)
Exome sequencing of Norwegian families with PD reveals novel gene mutations

 

Alexandru Hanganu (Canada)
Mild Cognitive Impairment in Parkinson’s disease is linked with extensive cortical thinning during longitudinal analysis

 

Maryka Quik (USA)
Nicotine and nicotinic receptor drugs reduce L-dopa-induced dyskinesias in a nonhuman primate model of Parkinson's disease

Ryan Duncan (USA)
Balance differences between people with and without freezing of gait in Parkinson disease


Day 2 – October 3

Hot Topics

8-9AM
Plenary Hall 517ABC


Moderator: Oscar Gershanik (Argentina)

Martijn van der Eijk (The Netherlands)
Patient-centered care in the Parkinson centers of excellence: a multicenter study

 

Andrew Vo (Canada)

Recasting the role of dorsal striatum in learning and decision-making: A study in Parkinson’s disease


Elisaveta Sokolov (UK)
Non-motor clinical staging using the non-motor symptoms scale and motor correlation in an UK cohort of Parkinson’s

 

Ariadna Recasens Ibabe (Spain)
Lewy body fractions from patients with Parkinson’s disease initiate synuclein-dependent neurodegeneration in mice and non-human primates



Day 3
– October 4

Hot Topics
8-9AM
Plenary Hall 517ABC

 

Moderator: Eduardo Tolosa (Spain)

 

Bin Hu (Canada)

Concurrent Arm Swing-Stepping (CASS) test for dual task-related movement in-coordination and hesitation in Parkinson’s disease

Ianai Fishbein (USA)

Altered Alpha Synuclein degradation and augmentation of Parkinson disease phenotype in a transgenic mouse model

 

Daniel Levesque (Canada)

Unilateral 6-OHDA lesion and Dopa administration in Nur77 knockout rats reveal an important role of this transcription factor in Parkinson’s disease and its treatment 


Rob Skelly (UK)
Does a specialist Parkinson’s unit improve outcomes for hospitalised Parkinson’s patients?

Membership Management Software Powered by YourMembership.com®  ::  Legal/Privacy